Hamartoma MRI: Difference between revisions

Jump to navigation Jump to search
 
(6 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Hamartoma}}
{{Hamartoma}}
{{CMG}}{{AE}}{{MV}}
{{CMG}}{{AE}}{{MV}} {{VKG}}


==Overview==
==Overview==
MRI is the modality of choice for assessment of hypothalamic, [[spleen]], [[kidney]], and other abdominal hamartomas. On MRI, hamartoma is characterized by a heterogeneous signal in [[T1]] and high signal due to fat and cartilaginous components in T2.
[[Magnetic resonance imaging|MRI]] is the modality of choice for assessment of [[hypothalamic]], [[spleen]], [[kidney]], and other abdominal [[hamartomas]]. On [[Magnetic resonance imaging|MRI]], [[hamartoma]] is characterized by a [[heterogeneous]] signal in [[T1]] and high signal due to fat and [[cartilaginous]] components in [[T2 phage|T2]].


==MRI==
==MRI==
*MRI is the modality of choice for assessment of hypothalamic, spleen, kidney, and other abdominal hamartomas.<ref name="radio">Hypothalamic hamartoma.Dr Donna D'Souza et al. Radiopedia.http://radiopaedia.org/articles/pulmonary-hamartoma-1 Accessed on December 09, 2015</ref>  
MRI may be helpful in the diagnosis of [[hamartomas]]. Findings on MRI suggestive of [[hamartomas]] include:<ref name="radio">Hypothalamic hamartoma.Dr Donna D'Souza et al. Radiopedia.http://radiopaedia.org/articles/pulmonary-hamartoma-1 Accessed on December 09, 2015</ref><ref name="pmid27936889">{{cite journal |vauthors=Leiter Herrán F, Restrepo CS, Alvarez Gómez DI, Suby-Long T, Ocazionez D, Vargas D |title=Hamartomas from head to toe: an imaging overview |journal=Br J Radiol |volume=90 |issue=1071 |pages=20160607 |date=March 2017 |pmid=27936889 |pmc=5601532 |doi=10.1259/bjr.20160607 |url=}}</ref><ref name="pmid17620469">{{cite journal |vauthors=Saleem SN, Said AH, Lee DH |title=Lesions of the hypothalamus: MR imaging diagnostic features |journal=Radiographics |volume=27 |issue=4 |pages=1087–108 |date=2007 |pmid=17620469 |doi=10.1148/rg.274065123 |url=}}</ref>
*T1: isointense to cerebral cortex  
*
*T1 contrast: no contrast enhancement  
*[[T1]]: isointense to [[cerebral cortex]]
*T2: iso to hyperintense to [[cerebral cortex]], the higher the proportion of glial cells, the higher the [[T2]] signal.
*[[T1]] contrast: no contrast enhancement  
*MR spectroscopy
*T2: iso to hyperintense to [[cerebral cortex]], the higher the proportion of [[Glial cell|glial]] cells, the higher the [[T2]] signal.
*[[Mitral regurgitation|MR]] [[spectroscopy]]
**Reduced NAA/C
**Reduced NAA/C
**Increased myoinositol
**Increased myo [[inositol]]
**Increased Cho/Cr compared to the [[amygdala]] has also been reported.
**Increased Cho/Cr compared to the [[amygdala]] has also been reported.


Line 30: Line 31:
Image:Biliary-hamartomas-MR-05.jpg|Biliary hamartomas([http://www.radswiki.net  Images courtesy of RadsWiki])
Image:Biliary-hamartomas-MR-05.jpg|Biliary hamartomas([http://www.radswiki.net  Images courtesy of RadsWiki])
</gallery>
</gallery>
<br style="clear:left" />


==References==
==References==

Latest revision as of 04:20, 5 April 2019

Hamartoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hamartoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hamartoma MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hamartoma MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hamartoma MRI

CDC on Hamartoma MRI

Hamartoma MRI in the news

Blogs on Hamartoma MRI

Directions to Hospitals Treating Hamartoma

Risk calculators and risk factors for Hamartoma MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2] Vamsikrishna Gunnam M.B.B.S [3]

Overview

MRI is the modality of choice for assessment of hypothalamic, spleen, kidney, and other abdominal hamartomas. On MRI, hamartoma is characterized by a heterogeneous signal in T1 and high signal due to fat and cartilaginous components in T2.

MRI

MRI may be helpful in the diagnosis of hamartomas. Findings on MRI suggestive of hamartomas include:[1][2][3]

Gallery

Hypothalamic Hamartoma

Biliar Hamartomas


References

  1. Hypothalamic hamartoma.Dr Donna D'Souza et al. Radiopedia.http://radiopaedia.org/articles/pulmonary-hamartoma-1 Accessed on December 09, 2015
  2. Leiter Herrán F, Restrepo CS, Alvarez Gómez DI, Suby-Long T, Ocazionez D, Vargas D (March 2017). "Hamartomas from head to toe: an imaging overview". Br J Radiol. 90 (1071): 20160607. doi:10.1259/bjr.20160607. PMC 5601532. PMID 27936889.
  3. Saleem SN, Said AH, Lee DH (2007). "Lesions of the hypothalamus: MR imaging diagnostic features". Radiographics. 27 (4): 1087–108. doi:10.1148/rg.274065123. PMID 17620469.


Template:WikiDoc Sources